Description
Caplacizumab is a drug used to treat thrombotic thrombocytopenic purpura (aTTP) and thrombosis. It’s also known by the brand name Cablivi.
This drug was developed by Ablynx NV. On 30 August 2018, it was approved in the European Union for the “treatment of adults experiencing an episode of acquired thrombotic thrombocytopenic purpura (aTTP), in conjunction with plasma exchange and immunosuppression.
In February 2019, caplacizumab-yhdp (Cablivi, Ablynx NV) was approved in the United States for the treatment of adults with acquired thrombotic thrombocytopenic purpura (aTTP). The drug is used in combination with plasma exchange and immunosuppressive therapy. The U.S. Food and Drug Administration (FDA) considers it to be a first-in-class medication.
NEWS / UPDATEs
- EU/3/09/629 – orphan designation for treatment of thrombotic thrombocytopenic purpura
- “Cablivi Product information”. Health Canada. 25 April 2012. Retrieved 29 May 2022.
Get Access to CABLIVI (caplacizumab-yhdp)In India
Medvitaz Pharma is equipped to facilitate the distribution of CABLIVI (caplacizumab-yhdp) (prescription medications) worldwide and throughout India upon completion of necessary legal procedures, if applicable.
To inquire about the price of either the branded medication “CABLIVI (caplacizumab-yhdp)” or the generic version “caplacizumab-yhdp” for personal use under patient-specific treatment in various cities including Delhi, Mumbai, Kolkata, Chennai, Bangalore, Hyderabad, Ahmedabad, Pune, Surat, Jaipur, Coimbatore, Noida, Gurgaon, Punjab, Chandigarh, Bhubaneswar, Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland, Tripura, Sikkim, and others in India, please fill out the request form. Upon receiving your request and assessing the delivery process, we will provide you with an estimated price for the medication within 24 hours.
For any inquiries or assistance, please reach out to our Patient Support Team. We are available to assist you from Monday to Friday, between 9:00 and 19:00 IST. You can contact us via email at [email protected], toll-free at +91 8750295029, or through WhatsApp at +91-8750295029.